Clinical Dynamix
The Director, Clinical Development – Inflammation will lead the design, execution, and oversight of clinical trials for the company's inflammation portfolio. This role shapes clinical strategy, collaborates cross‑functionally with research, regulatory, safety, and commercial teams, and mentors junior staff to advance innovative therapies for inflammatory diseases.
Clinical Dynamix matches exceptional talent with cutting-edge companies focused in: Pharmaceutical, Biotechnology, Medical Device/Diagnostics & Gene Therapy
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Clinical Dynamix.
Clinical Dynamix didn’t post a salary, so this is our estimate from similar listings.
15% below the average for this role
Senior Director, Clinical Development (MD), Inflammation and Immunology
Gilead Sciences
Senior Director, Clinical Development - Dermatology (MD)
Gilead Sciences
Director, Clinical Development (MD)
Gilead Sciences
Senior Medical Director, Early R&I Clinical Development, Rheumatology/Clinical Immunology
AstraZeneca
Executive Medical Director, Clinical Development - Immunology
lifelancer
Sr Scientist, Biomarkers & Translational Inflammation
Gilead Sciences